Member Info for beinthelead

This isn’t about being friends Marik. This is an anonymous BB, don’t over think it.

It’s a mess of a place. Posters recognise genuine posts, and look out for their input. Pretty simple really. This BB is full of $h1te. Literally tosh. The people that add value, stand out. Genuinely.

Marik once again trolling the board with his patronising, repetitive, apathetic musings. Hell bent on disruption and aggravation.

Your traits are almost identical to The Bishop.

Bella - I do appreciate your optimism and info.

Bella - fair point. I’d argue they’d have kept quiet until the test was available, if it were close.

Anyway, we all live in hope.

Nothing yesterday, back today when we’re red. Fascinating.

Based on that post, and Al’s questionable judgement, I trust you’ve ‘paired down’ your holding? Or will you only declare this if it falls further. Think we know the answer.

Bella - I agree with you. As I said, they’re likely not live samples either. It’s politics and PR semantics. We’ve came out of the long grass. For the better/worse, we’ll see.

Monkshood - it’s almost definitely a Spike driven issue that is bottlenecked by the Ab. Next generation would suggest N-S hybrid. As like you, it’s head scratching that others have proven to be effective - although, were the samples real-world, or contrived?

Either way, it’s back to the drawing board and we wait an update.

You said it earlier. The shorts closing will add more value than our recent LFT tribulations. I’m as gutted as the next man. But like you, hoping it retires me in a few years.

Cheers Rip.

You’re bang on with the LFT - whenever you think it’s done; it’s not. The amount of times I’ve been on the blower to an investor mate and said, ‘right that’s it, it’s now totally derisked’ :). Rev 27 will see it nearly there.

Thanks Reaper. Yes, it’s quite clear they like the multiplexing tests. Implying that they’ll pass them based on a theoretical basis! Let’s hope ABDX have a good group of LFT specialists on board. I’m sure they have.

Wrong.

My post gave my view on the origin of the test. Where I think we’re at in terms of development, and why I felt that we were valid to target the Spike using Affimers only.

Again, there’s no need for you to police this thread. Stay away.

Stop being so disruptive and contrary for no reason other than to troll.

We haven’t deviated from anything. You may have a view - good luck with that.

The topic centred around an area you weren’t keen or chose not to support. As suggested, you might want to stay away from this thread.

Marik - suggest you stay away from this thread.

Thought that today. They close, we’re back to placing. That momentum will be worth more than CE self test RNS. Mental.

Marik - You are free to leave at any time. This is not about personal grievances or whining. If you are that way out, ignore the remainder of this thread.

Bella - thanks for the link.

I disagree - Using Ab’s in the LFT wasn’t the only way they could get the CE Mark. They needed Mologic to design an LFT and use their ISO status to get the CE Mark. They could have designed any device fit to be used as a personal Cov2 detection measure.

The point is, all but those with hindsight we’re led to believe the product was powered and reliant on Affirmers only. It is news the majority that the LFT is reliant on an Ab.

And no Marik, those that failed to realise were not under researched or naive.

Forgetting Medusa, we KNOW we have 1m/month from GAD, and a further 2m/month from ABDX.

No need to speculate on Medusa to underpin the TD note.

Telegram nonsense, Zoom.

Marik - you stated that I was NOT misled. Shutting down debate with opinion is not a debate.

It’s immaterial - the test is no longer valid for the market as it is not sensitive enough. It needs fixed as it relies on an Ab.

Marik - are you incapable of debating?

Ndn71 - Agree. My handful of posts on the matter are not clear enough for Bella/Marik.